Results 211 to 220 of about 78,261 (320)
Successful immunological treatment of gallbladder cancer in India—Case report [PDF]
Jamal Khan, Sharmin Yaqin
openalex +1 more source
ABSTRACT Background & Aims Angiogenesis is critical in intrahepatic cholangiocarcinoma (ICC), a highly lethal cancer with limited treatment options. Sunitinib, a multi‐receptor tyrosine kinase inhibitor, has strong antiangiogenic and antitumor effects.
Louis Gros+16 more
wiley +1 more source
Neoadjuvant treatment for incidental gallbladder cancer: A systematic review. [PDF]
Varshney P+8 more
europepmc +1 more source
A CASE OF METACHRONOUS QUINTUPLE CANCER OF THE COLON, GALLBLADDER, STOMACH, LUNG AND PROSTATE
Shinya Asami+4 more
openalex +2 more sources
Liver Involvement in Celiac Disease and Immune‐Mediated Diseases of the Small Bowel
ABSTRACT Disorders of the hepatobiliary system are commonly associated with gastrointestinal (GI) diseases. The GI and hepatobiliary systems interact through the portal vein system and enterohepatic circulation, creating a gut–liver axis that allows for a complex multidirectional interplay between immune, hormonal, dietary and environmental luminal ...
Nicoletta Nandi+8 more
wiley +1 more source
Molecular Mechanisms of Lymph Node Metastasis in Gallbladder Cancer: Insights into the Tumor Microenvironment. [PDF]
Tang Q, Guan Y, Ma Y, Li Q, Geng Z.
europepmc +1 more source
A STUDY ON SUBSEROSAL CANCER INFILTRATION AND PROGNOSIS IN RESECTED t2 GALLBLADDER CARCINOMAS
Masashi Mizumoto+11 more
openalex +2 more sources
Two distinct pathways of p16 gene inactivation in gallbladder cancer [PDF]
Hiroyuki Hiroyuki
openalex +1 more source
Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors
Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi+6 more
wiley +1 more source